Because of the risks of corporal rupture or other serious penile injury, XIAFLEX is available for the treatment of Peyronies disease only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the XIAFLEX REMS Program
Track progress through multiple metrics: scale weight (understanding water fluctuations affect this), body measurements at consistent points, progress photos in consistent lighting and posture, and subjective assessments of how clothing fits
Pulling back a tiny bit of air first can help you get all the liquid out of the needle hub when you're done
There is a significant disconnect between the official medical understanding and the patients reality
AOD-9604 holds no Health Canada human or veterinary use authorization, and Health Canada has stated in public advisories that unauthorized injectable peptide products are illegal regardless of the 'for research use only' labelling on the container
Science translational medicine, 2015, 7